Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis

Diseases of the Colon and Rectum

Volumn 41, Issue 1, 1998, Pages 93-97

  Gionchetti, P ^a,b   Rizzello, F ^a   Venturi, A ^a   Ferretti, M ^a   Brignola, C ^a   Miglioli, M ^a   Campieri, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Mesalazine suppositories; Mesalazine tablets; Topical treatment; Ulcerative proctitis

Indexed keywords

ENEMA; MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PROCTITIS; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SINGLE BLIND PROCEDURE;

ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MESALAMINE; PROCTITIS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0031963091     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236902     Document Type: Article

References (19)

1. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987; 92:1894-8.
2. Campieri M, Gionchetti P, Belluzzi A, et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 1991;32: 929-31.
3. Van Hogezand RA, van Hees PA, van Gorp JP, et al. Double-blind comparison of 5-aminosalicylic and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol Ther 1988; 2:33-40.
4. Campieri M, Gionchetti P, Belluzzi A, et al. Topical treatment with 5-aminosalicylic acid in distal ulcerative colitis by using a new suppository preparation: a double blind placebo controlled trial. Int J Colorectal Dis 1990;5:79-81.
5. Vitti RA, Meyers F, Knight LC, et al. Quantitative distribution of radiolabeled 5-aminosalicylic acid enema in patients with left-sided ulcerative colitis. Dig Dis Sci 1989;34:1792-7.
6. Campieri M, Corbelli C, Gionchetti P, et al. Spread and distribution of 5-ASA colonie foam and 5-ASA enema in patients with ulcerative colitis. Dig Dis Sci 1992;37: 1890-7.
7. Williams CN, Haber G, Aquino JA. Double blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99 Tc-labeled 5-ASA suppositories. Dig Dis Sci 1987;32:71S-5S.
8. Campieri M, Gionchetti P, Belluzzi A, et al. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol 1988;10:406-9.
9. Campieri M, De Franchis R, Bianchi Porro G, et al. Mesalazine(5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis: a randomized controlled trial. Scand J Gastroenterol 1990;25:663-8.
10. Kam L, Cohen H, Dooley C, et al. A comparison of mesalamine and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Am J Gastroenterol 1996;91:1338-42.
11. The Rowasa Study Group. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Gastroenterology 1995;108:A909.
12. Truelove SC, Richard WC. Biopsy studies in ulcerative colitis. BMJ 1956;i:1315-7.
13. Sninsky C, Cort D, Shanahan F, et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: a multicenter study. Ann Intern Med 1990;115:350-5.
14. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid in the treatment of active ulcerative colitis. N Engl Med 1987;317:1625-9.
15. Miglioli M, Bianchi-Porro G, Brunetti G, et al. Oral-delayed release mesalazine in the treatment of mild ulcerative colitis: a dose-ranging study. Eur J Gastroentol Hepatol 1990;2:229-34.
16. Rijk MCM, van Schaik A, van Tongeren JH. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds. Scand J Gastroenterol 1988;23: 107-12.
17. Christensen LA, Fallinborg J, Abildgaard K, et al. Topical and systemic availability of 5-aminosalicylate: a comparisons of three controlled release preparations in man. Aliment Pharmacol Ther 1990;4:523-33.
18. Gionchetti P, Campieri M, Venturi A, et al. Systemic availability of 5-aminosalicylic acid: comparison of delayed release and an azo-bond preparation. Aliment Pharmacol Ther 1996;10:601-5.
19. Jacobsen BA, Abildgaard K, Rasmussen HH, et al. Availability of mesalazine(5-aminosalicylic acid) from enemas and suppositories during steady-state conditions. Scand J Gastroenterol 1991;26:374-8.